India, March 17 -- Camlin Fine Sciences Limited (CFSL) has announced a delay in filing its simplified cash tender offer (OPAS) for the remaining shares of France-based Vinpai, citing administrative constraints related to Indian foreign exchange regulations and the proximity of Vinpai's FY25 results announcement.
The company had earlier completed the acquisition of a majority stake in Vinpai on November 27, 2025, acquiring 78.68% of the share capital and 84.89% of voting rights at a price of Euro 3.60 per share. Following the conversion of convertible bonds, CFSL's total holding increased to 83.82% of share capital and 80.86% of voting rights.
CFSL had initially planned to file the open offer by end-February 2026. However, it now expects t...